Search

Your search keyword '"R. A. Padua"' showing total 59 results

Search Constraints

Start Over You searched for: Author "R. A. Padua" Remove constraint Author: "R. A. Padua"
59 results on '"R. A. Padua"'

Search Results

1. Standardizing electrocardiographic and arterial pressure parameters in creole horses of the Bogotá Savannah

2. Estandarización de parámetros electrocardiográficos y presión arterial en caballos criollos de la Sabana de Bogotá

Catalog

Books, media, physical & digital resources

3. Estandarización de parámetros electrocardiográficos y presión arterial en caballos criollos de la Sabana de Bogotá

4. Clinical features and corneal optical anisotropies in a rabbit model of limbal stem cell deficiency

5. Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?

6. Regulation of Ryanodine Receptor Calcium Release Channels by Diadenosine Polyphosphates

7. Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent

8. 175 ADJUVANT, PVAX14 DNA, AS AN IMMUNOTHERAPY FOR A MOUSE MODEL OF HIGH RISK MYELODYSPLASTIC SYNDROME (HR-MDS) EXTENDS SURVIVAL AS ADD-ON TREATMENT TO AZACITIDINE (AZA)

9. Royal Academy of Medicine in Ireland Section of Biomedical Sciences

10. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium

11. Rat Brain Adenosine Deaminase After 2'-Deoxycoformycin Administration: Biochemical Properties and Evidence for Reduced Enzyme Levels Detected by 2'-[3H]Deoxycoformycin Ligand Binding

12. The malignant histiocytosis sarcoma virus, a recombinant of Harvey murine sarcoma virus and Friend mink cell focus-forming virus, has acquired myeloid transformation specificity by alterations in the long terminal repeat

14. Direct synthesis of microwave filters using inverse scattering TLM (transmission line matrix) method

15. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML

16. Retinoic acid receptor alpha (RAralpha) Mutations in Human Leukemia

17. Oncogene mutation and prognosis in the myelodysplastic syndromes

18. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure

19. Fibroblast growth factor-2 stimulates phospholipase Cbeta in adult cardiomyocytes

20. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression

21. Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies

22. Flow cytometric apoptosis assays indicate different types of endonuclease activity in haematopoietic cells and suggest a cautionary approach to their quantitative use

23. RAS and the myelodysplastic syndromes

24. The cystic fibrosis delta F508 gene mutation and cancer

25. Subcellular localization of ryanodine receptors in rat brain

26. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia

27. A C-terminal FMS mutation in a patient with B-cell malignancy

28. Non-dysplastic myelodysplasia?

29. Clonal haemopoiesis following cytotoxic therapy for lymphoma

31. Expression of the colony-stimulating factor 1 receptor in B lymphocytes

32. Genetic lesions in preleukemia

33. High affinity [3H]ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine

35. Genetic lesions in preleukemia

36. C035 DNA vaccination as immunotherapy adjuvant in MDS

37. Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein

38. The MEL gene: a new member of the RAB/YPT class of RAS-related genes

39. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies

40. Molecular Genetics

41. Is the mdr 1 gene relevant in chronic lymphocytic leukemia?

42. Adenosine Deaminase and Adenosine Transport Systems in the CNS

43. Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma

44. Confirmation and refinement of the localisation of the c-MEL locus on chromosome 19 by physical and genetic mapping

45. RAS mutations in preleukaemias

46. Transformation of mononuclear phagocytes in vivo and malignant histiocytosis caused by a novel murine spleen focus-forming virus

47. N-methyl-N-nitrosourea-induced transformation of rat urothelial cells in vitro is not mediated by activation of ras oncogenes

48. Health and maternity insurance